Harlan（envigo）产品代理
Harlan（envigo）产品代理
这种组合意味着药物开发商和研究人员：
满足将新药物和医疗设备推向市场所需需求的集成解决方案。具有利用广泛研究模型组合的独特能力的发现和临床前领导者提供广泛的服务套件，使数据能够帮助您将分子推向市场。
一套综合的非临床和分析/生物分析服务，与最广泛和最具创新性的研究模型相结合
与一个组织合作的能力——Inotiv——支持他们的分子开发，用于整个发现和非临床开发，同时获得两家公司相同的高度个性化服务
在整个发现和临床前连续过程中获得深厚的专业知识和科学能力。这意味着支持客户从早期发现到研究性新药 (IND) 的能力得到增强。 Inotiv 带来了科学领导力、悠久而无可挑剔的监管历史以及世界一流的科学家团队，他们提供全面的非临床和分析/生物分析服务。 Envigo 在提供整个行业的关键研究模型方面拥有良好的记录和丰富的经验，包括：
大型研究模型，包括非人类灵长类动物 (NHP)
用于基础研究和药物发现的各种高质量、小型研究模型，以及专门的疾病和治疗领域特定模型
基因工程模型和服务 (GEMS)、合同育种服务、Teklad 实验室动物饮食、手术服务、动物健康监测和定制抗体制造服务
lnotiv Inc., a leading provider of nonclinical services and products, and Envigo, a leading global provider of research models, have joined together to provide a comprehensive suite of nonclinical and analytical/bioanalytical services, integrated with the widest and most innovative range of research models.
This combination means drug developers and researchers have:
Integrated solutions that meet the needs required to bring new drugs and medical devices to market. A discovery and preclinical leader with a unique ability to leverage expansive research model portfolio offers a broad suite of services that
enable data to help move your molecule to market.
A comprehensive suite of nonclinical and analytical/bioanalytical services integrated with the widest and most innovative range of research models
The ability to work with one organization — Inotiv — to support the development of their molecules for the entirety of discovery and nonclinical development while getting the same highly personalized service that characterizes both companies
Access to deep expertise and scientific capabilities across the discovery and preclinical continuum. This means an enhanced ability to support clients from early discovery through investigational new drug (IND). Inotiv brings scientific leadership, a long and impeccable regulatory history, and world-class team of scientists who deliver a comprehensive range of nonclinical and analytical/bioanalytical services. Envigo has a track record and deep experience with supply of critical research models across the industry, including:
Large research models, including non-human primates (NHPs)
Wide range of high-quality, small research models for basic research and drug discovery, as well as specialized disease and therapeutic area specific models
Genetically engineered models and services (GEMS), contractbreeding services, Teklad laboratory animal diets, surgical services, animal health monitoring, and custom antibody manufacturing services
